Fingerprint
Dive into the research topics of 'Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials
Srdan Verstovsek, Ruben Mesa, Vikas Gupta, David Lavie, Viviane Dubruille, Nathalie Cambier, Uwe Platzbecker, Marek Hus, Blanca Xicoy, Stephen T. Oh, Jean Jacques Kiladjian, Alessandro M. Vannucchi, Aaron Gerds, Miklos Egyed, Jiří Mayer, Tomasz Sacha, Jun Kawashima, Marc Morris, Mei Huang, Claire Harrison
- Department of Medicine
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Cancer Biology
- DBBS - Immunology
- DBBS - Molecular Cell Biology
- DBBS - Molecular Genetics and Genomics
- Division of Hematology
- Institute of Clinical and Translational Sciences (ICTS)
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Rheumatic Diseases Research Resource-Based Center
- Siteman Cancer Center
Research output: Contribution to journal › Article › peer-review
18
Scopus
citations